Unexpected Metastatic Localizations of Prostate Cancer Determined by 68Ga PSMA PET/CT: Series of Four Cases

dc.contributor.authorGözde MUTEVELİZADE
dc.contributor.authorCeren SEZGİN
dc.contributor.authorGül GÜMÜŞER
dc.contributor.authorElvan SAYİT
dc.date.accessioned2024-07-24T09:12:01Z
dc.date.available2024-07-24T09:12:01Z
dc.date.issued2022
dc.description.abstractProstate-specific membrane antigen (PSMA) is a transmembrane protein with overexpression in most prostate cancer cells. Gallium-68-(68Ga) PSMA positron emission tomography/computed tomography (PET/CT) imaging is a game-changer in the management of prostate cancer. 68Ga PSMA PET/CT scan is advanced and a promising radioligand has high sensitivity in determining lesions of prostate cancer with a high tumor to background ratio. The most common areas of metastasis are the bone and pelvic lymph nodes. The prognosis of prostate cancer is mainly determined by the status of metastases. The presence and the localization of metastases affects treatment planning. In our cases, we presented some examples of uncommon sites of metastases such as the brain, adrenal glands, penis and orbit. Improvements in imaging techniques, such as 68Ga PSMA PET/CT have led to the possibility to make more determination of rare metastase sites in prostate cancer patients.
dc.identifier.DOI-ID10.4274/mirt.galenos.2021.41033
dc.identifier.issn2146-1414
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/24173
dc.language.isoeng
dc.titleUnexpected Metastatic Localizations of Prostate Cancer Determined by 68Ga PSMA PET/CT: Series of Four Cases
dc.typeDiğer

Files